Techniques for targeting screening in ulcerative colitis

Postgraduate Medical Journal

Volumn 83, Issue 981, 2007, Pages 451-460

  Hurlstone, David Paul ^a,b   Brown, Steve ^c  

^a Royal Hallamshire Hospital ^*  (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DYE;

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHROMOENDOSCOPY; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; CONFOCAL LASER MICROSCOPY; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIUM TUMOR; EVIDENCE BASED PRACTICE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IN VIVO STUDY; PRACTICE GUIDELINE; REVIEW; SCREENING TEST; TUMOR CLASSIFICATION; ULCERATIVE COLITIS;

CHRONIC DISEASE; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSENSUS; EVIDENCE-BASED MEDICINE; FORECASTING; HUMANS; MASS SCREENING; TUMOR MARKERS, BIOLOGICAL;

EID: 34547222382     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.057257     Document Type: Review

References (76)

1. Crohn B, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925;170:220-8.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
3. Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;81:800-6.
4. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74.
5. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: The predictive value of low grade dysplasia. Gastroenterology 1992;103:431-8.
6. Fuson JA, Farmer RG, Hawk WA, et al. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980;73:120-6.
7. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158-63.
8. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;34:1536-41.
9. Leidenius M, Kellokumpu I, Husa A, et al. Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance programme. Gut 1991;32:1521-5.
10. Lofberg R, Brostrom O, Karlen P, et al. Colonoscopic surveillance in long-standing total ulcerative colitis-A 15 year follow-up study. Gastroenterology 1991;99:1021-31.
11. Lynch DA, Lobo AJ, Sobala GM, et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075- 80.
12. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
13. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut 1988;29:206-17.
14. Brostrom MO, Lofberg R, Ost A. Cancer surveillance of patients with longstanding ulcerative colitis: A clinical and endoscopical and histological study. Gut 1986;27:1408-13.
15. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med 1987;316:1654-8.
16. Goldmann H. Significance and detection of dysplasia in chronic colitis. Cancer 1996;78:2261-3.
17. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 1983;14:931-68.
18. Shelton AA, Lehman RE, Schrosck TR, et al. Retrospective review of colorectal cancer in ulcerative colitis at a tertiary centre. Arch Surg 1996;131:806-10.
19. Eaden JA, Mayberry JF. Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol 2000;95:2710-19.
20. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33.
21. Rutegard J, Ahsgren L, Stenling R, et al. Cancer surveillance in an unselected population. Scand J Gastroenterology 1988;23:139-45.
22. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990;31:1089-92.
23. Axon ATR. Cancer surveillance in ulcerative colitis - a time for reappraisal. Gut 1994;35:587-9.
24. Choi PM. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
25. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994;35:1419-23.
26. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? Gut 1998;42:711-14.
27. Koobatian GJ, Choi PM. Safety of surveillance colonoscopy in long-standing ulcerative colitis. Am J Gastroenterol 1994;89:1472- 5.
28. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;28:383-8.
29. Bernstein CN. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy? Gastroenterology 1999;117:1488-92.
30. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal neoplasia. Gut 2000;47:251-5.
31. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999;117:1288-94.
32. Fogt F, Urbanski SJ, Sanders ME, et al. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patinets with ulcerative colitis. Hum Pathol 2000;31:288-91.
33. Tytgat GN, Dhir V, Gopinath N. Endoscopic appearances of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer 1995;31:1174-7.
34. Bernstein CN, Shanahan F, Weinstein WM. Are we telling the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
35. Bernstein CN, Weinstein WM, Levine DS, et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995;90:2106-14.
36. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295- 300.
37. Odze RD, Brown CA, Hartmann CJ, et al. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMS are similar to non-colitic sporadic adenomas. Am J Surg Pathgol 2000;24:1209-16.
38. Rubin CE, Haggit RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
39. Dixon MF, Brown LJR, Gilmour HM, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-97.
40. Hurlstone DP, Sanders DS, Hunter MD, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut 2006;56:838-46.
41. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005;37:1186-92.
42. Hurlstone DP, McAlindon ME, Sanders DS, et al. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2004;126:376-8.
43. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepitheial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880- 8.
44. Kiesslich R, Hoffman A, Neurath MF. Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods. Endoscopy 2006;38:5-10.
45. Paris Workshop Participants. The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach and colon. Gastrointest Endosc 2002;58:S3-43.
46. Hurlstone DP, Fujii T. Practical uses of chromoendoscopy and magnification at colonoscopy. Gastrointest Endosc Clin N Am 2005;15:687-702.
47. Hurlstone DP, Cross SS, Adam I, et al. Endoscopic morphological anticipation of submucosal invasion in flat and depressed colorectal lesions: clinical implications and subtype analysis of the Kudo type V pit pattern using high-magnification-chromoscopic colonoscopy. Colorectal Disease 2004;6:369-75.
48. Kosaka T. Clinicopathological study of the minute elevated lesion of the colorectal mucosa. Journal of the Japanese Society of Coloproctology 1975;28:218-26.
49. Nishizawa Mea. Pertaining to histopathogenesis, growth and progression of early cancer of the colon and rectum in terms of dissecting microscopy and clinical aspects. Stomach and Intestine 1985;20:1036-41.
50. Kudo S, Rubio CA, Teixeira CR, et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001;33:367-73.
51. Hurlstone DP, Cross SS, Adam I, et al. Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis. Gut 2004;53:284-90.
52. Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol 2005;20:173-91.
53. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
54. Hurlstone DP, Fujii T, Lobo AJ. Early detection of colorectal cancer using high-magnification chromoscopic colonoscopy. Br J Surg 2002;89:272-82.
55. Odze RD, Farraye FA, Hecht JL, et al. Long-trem follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004;2:534-41.
56. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
57. Negent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
58. Hurlstone DP, Cross SS, Adam I, et al. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the UK. Am J Gastroenterol 2003;98:2543-9.
59. Hurlstone DP, Cross SS, Slater R, et al. Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Gut 2004;53:376-80.
60. Brooker JC, Saunders BP, Shah SG, et al. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc 2002;56:333-8.
61. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
62. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Nan Cancer Inst 1990;82:1769-72.
63. Brooker JC, Saunders BP, Shah SG, et al. Treatment with argon plasma coagulation reduces recurrence after piecmeal resection of large sessile colonic polyps: a randomised trial and recommendations. Gastrointest Endosc 2002;55:371-5.
64. Ahmad NA, Kochman ML, Long WB, et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002;55:390-6.
65. Hurlstone DP, Cross SS, Brown S, et al. A prospective evaluation of high-magnification chromoscopic colonoscopy in predicting completeness or EMR. Gastrointest Endosc 2004;59:642-50.
66. Hurlstone DP, Sanders DS, Cross SS, et al. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut 2004;53:1334-9.
67. Kiesslich R, Burg J, Vieth M, et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004;127:706-13.
68. Kiesslich R, Goetz M, Lammersdorf K. Chromoscopy guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis with reduced number of biopsies. Gastroenterology 2007;132:874-82.
69. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998;68:603-32.
70. Kapadia CR, Cutruzzola FW, O'Brien KM, et al. Laser-induced fluorescence spectroscopy of human colonic mucosa. Detection of adenomatous transformation. Gastroenterology 1990;99:150-7.
71. Haringsma J, Tytgat GNJ, Yano H, et al. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 2001;53:642-50.
72. Cothren RM, Richards-Kortum R, Sivak MV, et al. Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy. Gastrointest Endosc 1990;36:105-11.
73. Cothren RM, Sivak MV, Van Dam J, et al. Detection of dysplasia at colonoscopy using laser-induced fluorescence: a blinded study. Gastrointest Endosc 1996;44:168-76.
74. Chwirot BW, Kowalska M, Sypniewska N, et al. Spectrally resolved fluorescence imaging of colonic adenomas. J Photochem Photobiol 1999;50:174-83.
75. Wang TD, Van Dam J, Crawford JM, et al. Fluorescence endoscopic imaging of human colonic adenomas. Gastroenterology 1996;111:1182-91.
76. Wang TD, Crawford JM, Feld MS, et al. In vivo identification of colonic dysplasia using fluorescence endoscopic imaging. Gastrointest Endosc 1999;49:447-55.